Showing results (851-860 of 1,272) with videos related to

Sort By:
Pageof 128
The New England Journal of Medicine|June 11, 1987
Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosisT Takvorian, G P Canellos, J Ritz, et al.
American Journal of Epidemiology|June 20, 2018
Combining a Food Frequency Questionnaire With 24-Hour Recalls to Increase the Precision of Estimation of Usual Dietary Intakes-Evidence From the Validation Studies Pooling ProjectLaurence S Freedman, Douglas Midthune, Lenore Arab, et al.
Controlled Clinical Trials|April 1, 1990
Issues in the design of drug trials for AIDSS B Green, S S Ellenberg, D Finkelstein, et al.
American Journal of Epidemiology|September 15, 1995
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomizationS B Green, D K Corle, M H Gail, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 21, 2017
The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS studyMark S Freedman, Thomas P Leist, Giancarlo Comi, et al.
Lancet (London, England)|August 8, 1987
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy aloneL S Freedman, M C Parkinson, W G Jones, et al.
Science (New York, N.Y.)|September 17, 1976
Solar neutrinos: proposal for a new testM S Freedman, C M Stevens, E P Horwitz, et al.
Neuroimage|June 5, 2007
Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesionJ T Chen, T Kuhlmann, G H Jansen, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practiceMark S Freedman, Giancarlo Comi, Nicola De Stefano, et al.
Anticancer Research|December 25, 2009
Differential expression of CD3zeta message and protein in tumor infiltrating lymphocytes from solid tumor specimens and malignant ascites from patients with ovarian carcinomaJohn Pappas, Alexey D Wolfson, Weon J Jung, et al.
Pageof 128